According to the UnivDatos, the rising prevalence of type 2 diabetes and obesity, innovations such as oral formulations and long-acting drugs, increased patient awareness, and regulatory approvals drive the GLP-1 Analogues market. As per their “GLP-1 Analogues Market” report, the global market was valued at USD 37 Billion in 2023, growing at a CAGR of about 28% during the forecast...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek